Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease

J Biol Chem. 2018 Jun 29;293(26):10026-10040. doi: 10.1074/jbc.RA117.000567. Epub 2018 May 8.


Asthma is a chronic inflammatory disease of the lungs and airways and one of the most burdensome of all chronic maladies. Previous studies have established that expression of experimental and human asthma requires the IL-4/IL-13/IL-4 receptor α (IL-4Rα) signaling pathway, which activates the transcription factor STAT6. However, no small molecules targeting this important pathway are currently in clinical development. To this end, using a preclinical asthma model, we sought to develop and test a small-molecule inhibitor of the Src homology 2 domains in mouse and human STAT6. We previously developed multiple peptidomimetic compounds on the basis of blocking the docking site of STAT6 to IL-4Rα and phosphorylation of Tyr641 in STAT6. Here, we expanded the scope of our initial in vitro structure-activity relationship studies to include central and C-terminal analogs of these peptides to develop a lead compound, PM-43I. Conducting initial dose range, toxicity, and pharmacokinetic experiments with PM-43I, we found that it potently inhibits both STAT5- and STAT6-dependent allergic airway disease in mice. Moreover, PM-43I reversed preexisting allergic airway disease in mice with a minimum ED50 of 0.25 μg/kg. Of note, PM-43I was efficiently cleared through the kidneys with no long-term toxicity. We conclude that PM-43I represents the first of a class of small molecules that may be suitable for further clinical development against asthma.

Keywords: SH2 domain; STAT transcription factor; STAT5; STAT6; allergen; asthma; cytokine; fungi; peptidomimetic.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Asthma / drug therapy*
  • Asthma / immunology
  • Asthma / metabolism
  • Cell Line
  • Drug Evaluation, Preclinical
  • Female
  • Humans
  • Lung / drug effects
  • Lung / immunology
  • Lung / metabolism
  • Mice
  • Molecular Targeted Therapy*
  • STAT5 Transcription Factor / chemistry*
  • STAT5 Transcription Factor / metabolism*
  • STAT6 Transcription Factor / chemistry*
  • STAT6 Transcription Factor / metabolism*
  • Small Molecule Libraries / chemistry
  • Small Molecule Libraries / pharmacology*
  • Small Molecule Libraries / therapeutic use
  • Structure-Activity Relationship
  • src Homology Domains


  • STAT5 Transcription Factor
  • STAT6 Transcription Factor
  • Small Molecule Libraries